18F-PBR06/Total Body PET Imaging in Patients With STEMI
NCT05269446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2024-11-12
Summary
The study will use 18F-PBR06/uExplorer to study the activation of macrophages and systemic perfusion in patients with ST-segment elevation myocardial infarction (STEMI) or stable angina (SA). Participants will receive the total-body PET/CT scan on the seventh day (Day 7, D7) and D180 of enrolment.
Conditions
Interventions
- PROCEDURE
-
percutaneous coronary intervention (PCI)
A family of minimally invasive procedures used to open clogged coronary arteries and restore blood flow. This is also a standard treatment for patients diagnosed with STEMI or SA
- DEVICE
-
total body PET/CT scan
all participants will receive a total-body PET/CT scan (uExplorer) after enrolment
- PROCEDURE
-
Coronary Angiography (CAG)
A procedure that uses X-ray imaging to visualize coronary arteries.
- DRUG
-
TSPO injection
Participants will receive one dose of the non-therapeutic administration of the radioactive TSPO tracer 18F-PBR06 before a whole-body scan by uExplorer
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-08
- Primary Completion
- 2024-05-31
- Completion
- 2024-11-10
Countries
- China
Study Locations
More Related Trials
-
Early Interim 18F-FDG-PET and 18F-FLT-PET for Predicting Treatment Response and Survival in Metastatic Breast Cancer
NCT04411966 ·Status: COMPLETED ·Phase: NA
-
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638 ·Status: RECRUITING ·Phase: PHASE2
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
NCT00612326 ·Status: COMPLETED
-
18F-FMPP PET MPI in the Detection of Coronary Artery Disease
NCT04596527 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
NCT05160480 ·Status: ENROLLING_BY_INVITATION
-
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
NCT05844306 ·Status: SUSPENDED ·Phase: NA
-
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
NCT07026110 ·Status: RECRUITING ·Phase: NA
-
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
NCT06755086 ·Status: NOT_YET_RECRUITING
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
NCT07039474 ·Status: NOT_YET_RECRUITING
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma
NCT02928861 ·Status: UNKNOWN ·Phase: NA
-
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
NCT01089998 ·Status: COMPLETED ·Phase: PHASE1
-
PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.
NCT01297088 ·Status: COMPLETED ·Phase: PHASE1
-
PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
NCT00236275 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED
-
Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor
NCT03721055 ·Status: UNKNOWN ·Phase: NA
-
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 ·Status: RECRUITING
-
Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
NCT05062395 ·Status: COMPLETED
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
NCT02931201 ·Status: UNKNOWN ·Phase: NA
-
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
NCT06164561 ·Status: RECRUITING
-
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
NCT01621906 ·Status: COMPLETED ·Phase: NA
-
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein
NCT00964275 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
NCT05828238 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA